\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-tender\\,\\ non\\-distended\\ abdominal\\ and\\ pelvic\\ exam\\.\\ \\ no\\ adnexal\\ tenderness\\.\\ \\ normal\\ wbc\\ count\\.\\ \\ stable\\ h\\&h\\.\\ \\ quantitative\\ hcg\\ of\\ 909\\ iu\\/l\\.\ \(0\)\
\-\ surgical\\ treatment\\ with\\ periodic\\ follow\\-up\\ evaluations\\ until\\ quantitative\\ hcg\\ returned\\ to\\ zero\\.\ \(0\)\
\-\ transvaginal\\ grayscale\\ and\\ color\\ flow\\ ultrasound\\ evaluation\\ of\\ the\\ pelvis\\ demonstrates\\ a\\ moderate\\ amount\\ of\\ free\\ fluid\\ in\\ pelvic\\ cul\\-de\\-sac\\.\\ \\ no\\ gestational\\ sac\\ is\\ seen\\ within\\ the\\ endometrium\\.\\ \\ there\\ is\\ a\\ heterogeneous\\ mass\\ anterior\\ to\\ right\\ ovary\\ with\\ adjacent\\ complex\\ fluid\\.\ \(0\)\
\-\ ectopic\\ pregnancy\ \(58\)\
\-\ 1\\.\\ ectopic\\ pregnancy\ \(0\)\
\-\ 2\\.\\ early\\ iup\\ \ \(0\)\
\-\ 3\\.\\ nonviable\\ iup\ \(0\)\
\-\ 27y\\/o\\ g0p0\\ white\\ female\\ with\\ 24\\ hours\\ of\\ abdominal\\ \\‚\\Ä\\úqueeziness\\.\\‚\\Ä\\ù\\ \\ last\\ menstrual\\ period\\ 2\\ weeks\\ ago\\,\\ but\\ \\‚\\Ä\\úlighter\\ than\\ usual\\.\\‚\\Ä\\ù\ \(0\)\
\-\ ectopic\\ pregnancy\\ if\\ defined\\ by\\ the\\ implantation\\ of\\ a\\ fertilized\\ ovum\\ outside\\ the\\ \\ endometrial\\ lining\\ of\\ the\\ uterus\\,\\ most\\ commonly\\ within\\ the\\ fallopian\\ tube\\ \\(95\\-97\\%\\)\\.\\ \\ the\\ incidence\\ of\\ ectopic\\ pregnancy\\ increased\\ throughout\\ the\\ 1970\\‚\\Ä\\ôs\\ and\\ 80\\‚\\Ä\\ôs\\,\\ presumably\\ secondary\\ to\\ the\\ increased\\ rate\\ of\\ pelvic\\ inflammatory\\ disease\\.\\ \\ the\\ associated\\ mortality\\ rate\\ decreased\\ following\\ this\\ rise\\ in\\ incidence\\,\\ because\\ of\\ increased\\ awareness\\ and\\ earlier\\ detection\\.\ \(0\)\
\-\ the\\ classic\\ triad\\ of\\ ectopic\\ pregnancy\\ consists\\ of\\ irregular\\ bleeding\\,\\ abdominal\\/pelvic\\ pain\\,\\ and\\ a\\ tender\\ adnexal\\ mass\\.\\ \\ only\\ 60\\%\\ of\\ cases\\ have\\ a\\ missed\\ menstral\\ period\\.\\ \\ signs\\ and\\ symptoms\\ can\\ present\\ early\\,\\ secondary\\ to\\ mass\\ effect\\ on\\ the\\ small\\ caliber\\ fallopian\\ tube\\.\\ \\ high\\ risk\\ groups\\ include\\ females\\ with\\ abnormal\\ fallopian\\ tubes\\ from\\ prior\\ infection\\,\\ developmental\\ defects\\,\\ or\\ prior\\ surgery\\,\\ having\\ an\\ iud\\ in\\ place\\,\\ in\\ vitro\\ fertilization\\,\\ and\\ a\\ prior\\ history\\ of\\ ectopic\\ pregnancy\\.\\ \\ this\\ patient\\ presented\\ with\\ irregular\\ bleeding\\,\\ but\\ without\\ pain\\ or\\ tenderness\\.\\ \\ she\\ had\\ none\\ of\\ the\\ above\\-described\\ risk\\ factors\\.\ \(0\)\
\-\ above\\ a\\ quantitative\\ hcg\\ level\\ of\\ 1500\\-2000\\ iu\\/l\\,\\ an\\ intrauterine\\ pregnancy\\ should\\ be\\ visualized\\ on\\ transvaginal\\ ultrasound\\,\\ if\\ present\\.\\ \\ this\\ level\\ is\\ called\\ the\\ discriminatory\\ zone\\.\\ \\ the\\ discriminatory\\ zone\\ for\\ transabdominal\\ ultrasound\\ evaluation\\ is\\ higher\\,\\ at\\ 6500\\ iu\\/l\\.\\ \\ \\ a\\ negative\\ ultrasound\\ examination\\ at\\ hcg\\ levels\\ below\\ the\\ discriminatory\\ zone\\ is\\ consistent\\ with\\ an\\ early\\ viable\\ intrauterine\\ pregnancy\\ or\\ an\\ ectopic\\ pregnancy\\ or\\ nonviable\\ intrauterine\\ pregnancy\\.\\ \\ because\\ this\\ patient\\‚\\Ä\\ôs\\ clinical\\ examination\\ was\\ fairly\\ benign\\ and\\ the\\ quantitative\\ hcg\\ was\\ below\\ the\\ discriminatory\\ zone\\,\\ the\\ clinician\\ elected\\ to\\ delay\\ surgical\\ or\\ medical\\ treatment\\ for\\ ectopic\\ pregnancy\\ at\\ this\\ initial\\ evaluation\\.\\ \\ the\\ patient\\ returned\\ for\\ follow\\-up\\ examination\\ in\\ 48\\ hours\\ with\\ an\\ unchanged\\ clinical\\ picture\\ and\\ a\\ quantitative\\ hcg\\ level\\ of\\ 1217\\ iu\\/l\\.\\ \\ because\\ the\\ hcg\\ level\\ was\\ not\\ rising\\ at\\ the\\ predicted\\ rate\\ for\\ a\\ normal\\ iup\\,\\ laproscopic\\ surgical\\ intervention\\ was\\ performed\\ at\\ that\\ time\\.\\ \\ subsequent\\ follow\\-up\\ examinations\\ were\\ performed\\ until\\ the\\ quantitative\\ hcg\\ levels\\ returned\\ to\\ zero\\.\\ \\ ectopic\\ pregnancy\\ was\\ confirmed\\ by\\ histopathologic\\ evaluation\\.\ \(0\)\
\-\ a\\ complex\\ adnexal\\ mass\\ in\\ the\\ presence\\ of\\ a\\ quantitative\\ hcg\\ level\\ above\\ the\\ discriminatory\\ zone\\ and\\ empty\\ uterus\\ is\\ highly\\ suggestive\\ of\\ an\\ extrauterine\\ gestation\\ and\\ is\\ the\\ most\\ common\\ sonographic\\ abnormality\\,\\ these\\ findings\\ should\\ be\\ considered\\ to\\ represent\\ ectopic\\ pregnancy\\ until\\ proven\\ otherwise\\.\\ \\ nonspecific\\ findings\\ that\\ should\\ heighten\\ a\\ clinician\\'s\\ suspicion\\ of\\ ectopic\\ pregnancy\\ include\\ the\\ visualization\\ of\\ a\\ fluid\\ filled\\ adnexal\\ mass\\ surrounded\\ by\\ an\\ echogenic\\ ring\\ \\(bagel\\ sign\\)\\ and\\ free\\ fluid\\ in\\ the\\ peritoneal\\ cavity\\/cul\\-de\\-sac\\.\\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ condous\\,\\ g\\,\\ kirk\\,\\ e\\,\\ lu\\,\\ c\\,\\ et\\ al\\.\\ \\ diagnostic\\ accuracy\\ of\\ varying\\ discriminatroy\\ zones\\ for\\ the\\ prediction\\ of\\ ectopic\\ pregnancy\\ in\\ women\\ with\\ a\\ pregnancy\\ of\\ unknown\\ location\\.ultrasound\\ obstet\\ gynecol\\.\\ 2005\\;\\ 26\\:770\\.\\ \ \(0\)\
\-\ daya\\,\\ s\\.\\ human\\ chorionic\\ gonadotropin\\ increase\\ in\\ normal\\ early\\ pregnancy\\.\\ am\\ j\\ obstet\\ gynecol\\ 1987\\;\\ 156\\:286\\.\ \(0\)\
\-\ gabrielli\\,\\ s\\,\\ romero\\,\\ r\\,\\ pilu\\,\\ g\\,\\ et\\ al\\.\\ accuracy\\ of\\ transvaginal\\ ultrasound\\ and\\ serum\\ hcg\\ in\\ the\\ diagnosis\\ of\\ ectopic\\ pregnancy\\.\\ ultrasound\\ obstet\\ gynecol\\ 1992\\;\\ 2\\:110\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pregnancy\\:\\ 0\\.41916662232198326\ \(0\)\
\-\ ectopic\\:\\ 0\\.32716760653360843\ \(0\)\
\-\ hcg\\:\\ 0\\.266871072150592\ \(0\)\
\-\ quantitative\\:\\ 0\\.23814724026908016\ \(0\)\
\-\ discriminatory\\:\\ 0\\.22753704717084175\ \(0\)\
\-\ the\\:\\ 0\\.1703403568716537\ \(0\)\
\-\ of\\:\\ 0\\.13921804700755422\ \(0\)\
\-\ zone\\:\\ 0\\.13747228091682054\ \(0\)\
\-\ obstet\\:\\ 0\\.12614899795381787\ \(0\)\
\-\ gynecol\\:\\ 0\\.12614899795381787\ \(0\)\
\-\ ultrasound\\:\\ 0\\.1228655133318953\ \(0\)\
\-\ adnexal\\:\\ 0\\.1135082783763279\ \(0\)\
\-\ transvaginal\\:\\ 0\\.10540253725644355\ \(0\)\
\-\ iup\\:\\ 0\\.10540253725644355\ \(0\)\
\-\ intrauterine\\:\\ 0\\.09502930690775638\ \(0\)\
\-\ fallopian\\:\\ 0\\.08992720144181364\ \(0\)\
\-\ pelvic\\:\\ 0\\.08897594621290256\ \(0\)\
\-\ nonviable\\:\\ 0\\.08696951835812028\ \(0\)\
\-\ level\\:\\ 0\\.08594548606317894\ \(0\)\
\-\ early\\:\\ 0\\.08204803583612819\ \(0\)\
\-\ returned\\:\\ 0\\.0802343340690177\ \(0\)\
\-\ and\\:\\ 0\\.07644121068616555\ \(0\)\
\-\ an\\:\\ 0\\.07617047024407246\ \(0\)\
\-\ sac\\:\\ 0\\.07601631658701703\ \(0\)\
\-\ zero\\:\\ 0\\.07600873094877907\ \(0\)\
\-\ until\\:\\ 0\\.07103723924303942\ \(0\)\
\-\ in\\:\\ 0\\.07078940259386449\ \(0\)\
\-\ evaluation\\:\\ 0\\.06941636836457903\ \(0\)\
\-\ accuracy\\:\\ 0\\.06664767232296995\ \(0\)\
\-\ fluid\\:\\ 0\\.06571957203971553\ \(0\)\
\-\ rate\\:\\ 0\\.06468955308113321\ \(0\)\
\-\ clinician\\:\\ 0\\.0643350018394596\ \(0\)\
\-\ above\\:\\ 0\\.061585994896746356\ \(0\)\
\-\ because\\:\\ 0\\.05966290937847381\ \(0\)\
\-\ should\\:\\ 0\\.05570270097538096\ \(0\)\
\-\ examination\\:\\ 0\\.05462746508280454\ \(0\)\
\-\ is\\:\\ 0\\.05455016707473987\ \(0\)\
\-\ mass\\:\\ 0\\.05434724605134932\ \(0\)\
\-\ at\\:\\ 0\\.05374104052610067\ \(0\)\
\-\ uterus\\:\\ 0\\.049919437658804224\ \(0\)\
\-\ to\\:\\ 0\\.04979768592268203\ \(0\)\
\-\ period\\:\\ 0\\.049758515804751546\ \(0\)\
\-\ was\\:\\ 0\\.04958606550565156\ \(0\)\
\-\ or\\:\\ 0\\.0494967552372714\ \(0\)\
\-\ incidence\\:\\ 0\\.04899068021853456\ \(0\)\
\-\ this\\:\\ 0\\.0488900460416063\ \(0\)\
\-\ prior\\:\\ 0\\.047763620017456695\ \(0\)\
\-\ below\\:\\ 0\\.04686839546584578\ \(0\)\
\-\ abdominal\\:\\ 0\\.04669009609164419\ \(0\)\
\-\ bleeding\\:\\ 0\\.046516231659376434\ \(0\)\
\-\ increased\\:\\ 0\\.0461630266429155\ \(0\)\
\-\ 909\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ fertilized\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ 6500\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ bagel\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ condous\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ kirk\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ discriminatroy\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ daya\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ gabrielli\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ pilu\\:\\ 0\\.045507409434168346\ \(0\)\
\-\ tube\\:\\ 0\\.0454765969633716\ \(0\)\
\-\ al\\:\\ 0\\.04522010626556073\ \(0\)\
\-\ levels\\:\\ 0\\.04511932825055814\ \(0\)\
\-\ et\\:\\ 0\\.04458254195340937\ \(0\)\
\-\ with\\:\\ 0\\.044576393522389575\ \(0\)\
\-\ free\\:\\ 0\\.04430148284206353\ \(0\)\
\-\ irregular\\:\\ 0\\.043938645087154754\ \(0\)\
\-\ complex\\:\\ 0\\.043849960604068046\ \(0\)\
\-\ lighter\\:\\ 0\\.04348475917906014\ \(0\)\
\-\ ovum\\:\\ 0\\.04348475917906014\ \(0\)\
\-\ menstral\\:\\ 0\\.04348475917906014\ \(0\)\
\-\ 1217\\:\\ 0\\.04348475917906014\ \(0\)\
\-\ heighten\\:\\ 0\\.04348475917906014\ \(0\)\
\-\ lu\\:\\ 0\\.04348475917906014\ \(0\)\
\-\ romero\\:\\ 0\\.04348475917906014\ \(0\)\
\-\ hours\\:\\ 0\\.04337580517914653\ \(0\)\
\-\ for\\:\\ 0\\.043124042896817386\ \(0\)\
\-\ tender\\:\\ 0\\.04160602839130895\ \(0\)\
\-\ surgical\\:\\ 0\\.04149169702560663\ \(0\)\
\-\ vitro\\:\\ 0\\.040936521223279086\ \(0\)\
\-\ fertilization\\:\\ 0\\.040936521223279086\ \(0\)\
\-\ risk\\:\\ 0\\.0406647439919679\ \(0\)\
\-\ g0p0\\:\\ 0\\.040027015729497746\ \(0\)\
\-\ extrauterine\\:\\ 0\\.040027015729497746\ \(0\)\
\-\ prediction\\:\\ 0\\.040027015729497746\ \(0\)\
\-\ 1970\\:\\ 0\\.03859192253504357\ \(0\)\
\-\ iud\\:\\ 0\\.03859192253504357\ \(0\)\
\-\ predicted\\:\\ 0\\.03859192253504357\ \(0\)\
\-\ laproscopic\\:\\ 0\\.03859192253504357\ \(0\)\
\-\ chorionic\\:\\ 0\\.03859192253504357\ \(0\)\
\-\ gonadotropin\\:\\ 0\\.03859192253504357\ \(0\)\
\-\ implantation\\:\\ 0\\.03747877777371669\ \(0\)\
\-\ 1987\\:\\ 0\\.03700332586517861\ \(0\)\
\-\ evaluations\\:\\ 0\\.03656927227993536\ \(0\)\
\-\ histopathologic\\:\\ 0\\.03656927227993536\ \(0\)\
\-\ by\\:\\ 0\\.036252260119418754\ \(0\)\
\-\ clinical\\:\\ 0\\.03606820611013353\ \(0\)\
\-\ endometrium\\:\\ 0\\.03580029634182694\ \(0\)\
\-\ awareness\\:\\ 0\\.03580029634182694\ \(0\)\
\-\ rising\\:\\ 0\\.03580029634182694\ \(0\)\
\-\ tenderness\\:\\ 0\\.03569092367533847\ \(0\)\
\-\ grayscale\\:\\ 0\\.03545612751860848\ \(0\)\
\-\ transabdominal\\:\\ 0\\.03513417908548118\ \(0\)\
\-\ elected\\:\\ 0\\.03513417908548118\ \(0\)\
\-\ normal\\:\\ 0\\.03485523601620672\ \(0\)\
\-\ human\\:\\ 0\\.034831755019067705\ \(0\)\
\-\ viable\\:\\ 0\\.034546622024827146\ \(0\)\
\-\ 1992\\:\\ 0\\.034021034324154306\ \(0\)\
\-\ include\\:\\ 0\\.03386217433790091\ \(0\)\
\-\ secondary\\:\\ 0\\.033733229878706174\ \(0\)\
\-\ performed\\:\\ 0\\.033669377253365204\ \(0\)\
\-\ triad\\:\\ 0\\.03354558241561622\ \(0\)\
\-\ zones\\:\\ 0\\.03354558241561622\ \(0\)\
\-\ presumably\\:\\ 0\\.033111528830372966\ \(0\)\
\-\ if\\:\\ 0\\.033067337548045805\ \(0\)\
\-\ menstrual\\:\\ 0\\.032907889562827426\ \(0\)\
\-\ lining\\:\\ 0\\.032907889562827426\ \(0\)\
\-\ empty\\:\\ 0\\.03252397176971893\ \(0\)\
\-\ rise\\:\\ 0\\.03234255289226455\ \(0\)\
\-\ groups\\:\\ 0\\.0321675009197298\ \(0\)\
\-\ periodic\\:\\ 0\\.03199838406904609\ \(0\)\
\-\ missed\\:\\ 0\\.03183481304364436\ \(0\)\
\-\ unchanged\\:\\ 0\\.03167643563591879\ \(0\)\
\-\ examinations\\:\\ 0\\.03108887857526476\ \(0\)\
\-\ tubes\\:\\ 0\\.03081916590034294\ \(0\)\
\-\ caliber\\:\\ 0\\.029866092711922587\ \(0\)\
\-\ fairly\\:\\ 0\\.029866092711922587\ \(0\)\
\-\ picture\\:\\ 0\\.029866092711922587\ \(0\)\
\-\ varying\\:\\ 0\\.029866092711922587\ \(0\)\
\-\ detection\\:\\ 0\\.02965378538081058\ \(0\)\
\-\ most\\:\\ 0\\.029618774091599718\ \(0\)\
\-\ surrounded\\:\\ 0\\.029254494788703102\ \(0\)\
\-\ present\\:\\ 0\\.029203440919922552\ \(0\)\
\-\ endometrial\\:\\ 0\\.029066228320156547\ \(0\)\
\-\ proven\\:\\ 0\\.028709757470167407\ \(0\)\
\-\ females\\:\\ 0\\.028624482413686113\ \(0\)\
\-\ consists\\:\\ 0\\.02829725238204812\ \(0\)\
\-\ gestation\\:\\ 0\\.028218692186356403\ \(0\)\
\-\ but\\:\\ 0\\.028143116559976374\ \(0\)\
\-\ findings\\:\\ 0\\.02808839829491368\ \(0\)\
\-\ mortality\\:\\ 0\\.027990172720964157\ \(0\)\
\-\ ovary\\:\\ 0\\.027843442456814374\ \(0\)\
\-\ patient\\:\\ 0\\.02776596787182798\ \(0\)\
\-\ gestational\\:\\ 0\\.02763113512570237\ \(0\)\
\-\ visualization\\:\\ 0\\.027231844533594896\ \(0\)\
\-\ treatment\\:\\ 0\\.027110247473224876\ \(0\)\
\-\ suspicion\\:\\ 0\\.027043578065048333\ \(0\)\
\-\ 2005\\:\\ 0\\.027043578065048333\ \(0\)\
\-\ am\\:\\ 0\\.026862159187593944\ \(0\)\
\-\ nonspecific\\:\\ 0\\.026744778023005903\ \(0\)\
\-\ peritoneal\\:\\ 0\\.026744778023005903\ \(0\)\
\-\ called\\:\\ 0\\.0265737280316945\ \(0\)\
\-\ within\\:\\ 0\\.026211952870767843\ \(0\)\
\-\ delay\\:\\ 0\\.026093183249485525\ \(0\)\
\-\ echogenic\\:\\ 0\\.026093183249485525\ \(0\)\
\-\ earlier\\:\\ 0\\.02599240266370265\ \(0\)\
\-\ higher\\:\\ 0\\.025844949485367506\ \(0\)\
\-\ color\\:\\ 0\\.02565488957106107\ \(0\)\
\-\ place\\:\\ 0\\.02565488957106107\ \(0\)\
\-\ sonographic\\:\\ 0\\.025608484870594157\ \(0\)\
\-\ women\\:\\ 0\\.025608484870594157\ \(0\)\
\-\ serum\\:\\ 0\\.025516950755164566\ \(0\)\
\-\ highly\\:\\ 0\\.025471805928255892\ \(0\)\
\-\ that\\:\\ 0\\.024697711997436787\ \(0\)\
\-\ 48\\:\\ 0\\.02464538057216318\ \(0\)\
\-\ developmental\\:\\ 0\\.02460744526138323\ \(0\)\
\-\ defects\\:\\ 0\\.024532429271401774\ \(0\)\
\-\ having\\:\\ 0\\.024532429271401774\ \(0\)\
\-\ factors\\:\\ 0\\.024070532994377312\ \(0\)\
\-\ ring\\:\\ 0\\.023969752408594436\ \(0\)\
\-\ intervention\\:\\ 0\\.02390367900121816\ \(0\)\
\-\ represent\\:\\ 0\\.02367907974767981\ \(0\)\
\-\ count\\:\\ 0\\.023494300500056357\ \(0\)\
\-\ suggestive\\:\\ 0\\.023172352066929053\ \(0\)\
\-\ last\\:\\ 0\\.02314408870901551\ \(0\)\
\-\ be\\:\\ 0\\.02308695897117562\ \(0\)\
\-\ filled\\:\\ 0\\.022896675889411373\ \(0\)\
\-\ outside\\:\\ 0\\.022843322767705336\ \(0\)\
\-\ increase\\:\\ 0\\.022843322767705336\ \(0\)\
\-\ amount\\:\\ 0\\.022764347989064914\ \(0\)\
\-\ references\\:\\ 0\\.022686604036413118\ \(0\)\
\-\ stable\\:\\ 0\\.022509779016293554\ \(0\)\
\-\ visualized\\:\\ 0\\.022220511360127652\ \(0\)\
\-\ 80\\:\\ 0\\.022197146121498687\ \(0\)\
\-\ considered\\:\\ 0\\.02217388981211664\ \(0\)\
\-\ diagnostic\\:\\ 0\\.021687902589573264\ \(0\)\
\-\ unknown\\:\\ 0\\.021563184360377734\ \(0\)\
\-\ subsequent\\:\\ 0\\.021542697804572807\ \(0\)\
\-\ moderate\\:\\ 0\\.021362009142932847\ \(0\)\
\-\ classic\\:\\ 0\\.02128375703909975\ \(0\)\
\-\ 60\\:\\ 0\\.02128375703909975\ \(0\)\
\-\ commonly\\:\\ 0\\.021056106771211208\ \(0\)\
\-\ confirmed\\:\\ 0\\.02098247489081587\ \(0\)\
\-\ throughout\\:\\ 0\\.020927955557689594\ \(0\)\
\-\ ago\\:\\ 0\\.020820672512597123\ \(0\)\
\-\ abnormality\\:\\ 0\\.02069835715440467\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.020595850753234456\ \(0\)\
\-\ presence\\:\\ 0\\.020445935551655775\ \(0\)\
\-\ pain\\:\\ 0\\.020365239606248253\ \(0\)\
\-\ defined\\:\\ 0\\.020300394519000724\ \(0\)\
\-\ otherwise\\:\\ 0\\.020284482322646433\ \(0\)\
\-\ 24\\:\\ 0\\.020174495866390467\ \(0\)\
\-\ wbc\\:\\ 0\\.020112718366924572\ \(0\)\
\-\ effect\\:\\ 0\\.019961541060512504\ \(0\)\
\-\ pelvis\\:\\ 0\\.01990233004692581\ \(0\)\
\-\ signs\\:\\ 0\\.01988763645949127\ \(0\)\
\-\ sign\\:\\ 0\\.01970045692184069\ \(0\)\
\-\ benign\\:\\ 0\\.019547381696361693\ \(0\)\
\-\ inflammatory\\:\\ 0\\.01924173406322709\ \(0\)\
\-\ cases\\:\\ 0\\.01913966463379221\ \(0\)\
\-\ initial\\:\\ 0\\.01908940255289332\ \(0\)\
\-\ flow\\:\\ 0\\.01895373742405867\ \(0\)\
\-\ white\\:\\ 0\\.018774491698164395\ \(0\)\
\-\ no\\:\\ 0\\.01850716350342329\ \(0\)\
\-\ adjacent\\:\\ 0\\.01844521266955576\ \(0\)\
\-\ medical\\:\\ 0\\.018084954355010417\ \(0\)\
\-\ only\\:\\ 0\\.017777722125017617\ \(0\)\
\-\ decreased\\:\\ 0\\.017626257910609417\ \(0\)\
\-\ negative\\:\\ 0\\.01761694237227699\ \(0\)\
\-\ infection\\:\\ 0\\.017189097212635788\ \(0\)\
\-\ on\\:\\ 0\\.017188427524085864\ \(0\)\
\-\ abnormal\\:\\ 0\\.01709601026627464\ \(0\)\
\-\ following\\:\\ 0\\.01707092151601973\ \(0\)\
\-\ weeks\\:\\ 0\\.01705426550946966\ \(0\)\
\-\ she\\:\\ 0\\.01693920510292643\ \(0\)\
\-\ time\\:\\ 0\\.016866614939353087\ \(0\)\
\-\ presented\\:\\ 0\\.016593953124926314\ \(0\)\
\-\ high\\:\\ 0\\.016172551003038816\ \(0\)\
\-\ common\\:\\ 0\\.01613783639302609\ \(0\)\
\-\ than\\:\\ 0\\.016130922366517537\ \(0\)\
\-\ these\\:\\ 0\\.016069123607905262\ \(0\)\
\-\ anterior\\:\\ 0\\.015888192195084805\ \(0\)\
\-\ symptoms\\:\\ 0\\.015569535394757469\ \(0\)\
\-\ none\\:\\ 0\\.015551048149407923\ \(0\)\
\-\ consistent\\:\\ 0\\.015429520352965404\ \(0\)\
\-\ surgery\\:\\ 0\\.015299172883408325\ \(0\)\
\-\ without\\:\\ 0\\.015009493402909243\ \(0\)\
\-\ associated\\:\\ 0\\.014998469156815103\ \(0\)\
\-\ can\\:\\ 0\\.014932830455493512\ \(0\)\
\-\ diagnosis\\:\\ 0\\.014751411578039124\ \(0\)\
\-\ small\\:\\ 0\\.01467858591491057\ \(0\)\
\-\ were\\:\\ 0\\.014668268497939315\ \(0\)\
\-\ exam\\:\\ 0\\.014324786839034551\ \(0\)\
\-\ demonstrates\\:\\ 0\\.014296007128474283\ \(0\)\
\-\ have\\:\\ 0\\.01421535489277398\ \(0\)\
\-\ had\\:\\ 0\\.014177847427899121\ \(0\)\
\-\ female\\:\\ 0\\.013731353763073398\ \(0\)\
\-\ seen\\:\\ 0\\.01339687516498567\ \(0\)\
\-\ disease\\:\\ 0\\.01194483640951386\ \(0\)\
\-\ there\\:\\ 0\\.01132257163972974\ \(0\)\
\-\ from\\:\\ 0\\.01130153431038635\ \(0\)\
\-\ not\\:\\ 0\\.01123376931717209\ \(0\)\
\-\ history\\:\\ 0\\.010871856191897915\ \(0\)\
\-\ right\\:\\ 0\\.009434356015815687\ \(0\)\
